We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWPH
826
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$23M 0.02%
+200,027
New +$30.4M
MYOK
827
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$22.9M 0.02%
438,537
+11,815
+3% +$628K
ACIA
828
DELISTED
Acacia Communications Inc
ACIA
$22.8M 0.02%
349,320
+217,410
+165% +$13.8M
XRAY icon
829
Dentsply Sirona
XRAY
$2.68B
$22.8M 0.02%
428,061
+157,200
+58% +$8.44M
WAT icon
830
Waters Corp
WAT
$37B
$22.8M 0.02%
102,100
-25,248
-20% -$5.45M
STT icon
831
State Street
STT
$50.6B
$22.8M 0.02%
384,539
-33,010
-8% -$1.83M
NNN icon
832
NNN REIT
NNN
$9.04B
$22.8M 0.02%
403,381
-41,949
-9% -$2.28M
MRO
833
DELISTED
Marathon Oil Corporation
MRO
$22.7M 0.02%
1,851,142
-54,518
-3% -$705K
SBUX icon
834
CALL
Starbucks
SBUX
$120B
$22.7M 0.02%
256,800
+18,900
+8% +$1.75M
LW icon
835
Lamb Weston
LW
$7.22B
$22.6M 0.02%
310,816
-94,028
-23% -$6.45M
NTRS icon
836
Northern Trust
NTRS
$22.4B
$22.6M 0.02%
241,999
+22,430
+10% +$2.06M
CTVA icon
837
Corteva
CTVA
$52.6B
$22.5M 0.02%
803,350
+134,940
+20% +$3.9M
MET icon
838
PUT
MetLife
MET
$61.9B
$22.5M 0.02%
476,700
-332,200
-41% -$15.8M
XHB icon
839
CALL
State Street SPDR S&P Homebuilders ETF
XHB
$1.6B
$22.5M 0.02%
510,000
+460,000
+920% +$19.3M
CPRT icon
840
Copart
CPRT
$27B
$22.4M 0.02%
1,112,916
-389,324
-26% -$7.56M
CLDR
841
PUT
DELISTED
Cloudera, Inc.
CLDR
$22.3M 0.02%
2,522,500
+162,500
+7% +$1.13M
SGMO
842
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$22.3M 0.02%
2,468,941
+104,529
+4% +$1.17M
TAP icon
843
Molson Coors Class B
TAP
$7.79B
$22.3M 0.02%
388,278
+11,715
+3% +$635K
TRU icon
844
TransUnion
TRU
$15.1B
$22.3M 0.02%
274,838
-200,853
-42% -$16.1M
GLPI icon
845
Gaming and Leisure Properties
GLPI
$12.7B
$22.3M 0.02%
582,124
+178,031
+44% +$6.83M
MLM icon
846
Martin Marietta Materials
MLM
$31.5B
$22.2M 0.02%
81,013
+4,865
+6% +$1.2M
NOC icon
847
Northrop Grumman
NOC
$77.1B
$22.2M 0.02%
59,123
-19,260
-25% -$6.82M
NTAP icon
848
NetApp
NTAP
$35B
$22.1M 0.02%
420,246
-10,491
-2% -$563K
IP icon
849
International Paper
IP
$21.6B
$22.1M 0.02%
556,852
+19,895
+4% +$777K
ARMK icon
850
Aramark
ARMK
$15B
$22M 0.02%
700,611
+379,658
+118% +$10.7M

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.